OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/19/2026
Back to search
Official data from USPTO
ZYPELZY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
03/20/2026
Trademark type
Word
Nice classes
5
Filing date
08/27/2024
Registration date
05/13/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/13/2025
Last transaction
03/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
HUDSON, TAMARA BREE
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
TAIHO PHARMACEUTICAL CO., LTD.
Representatives
No representative data.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations
Publications
History of USPTO decisions and trademark events.
13 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/02/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/02/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/12/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
05/13/2025
PUBO
PUBLISHED FOR OPPOSITION
03/25/2025
NPUB
NOTICE OF PUBLICATION
03/19/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/04/2025
DOCK
ASSIGNED TO EXAMINER
03/03/2025
MAFR
APPLICATION FILING RECEIPT MAILED
10/09/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/09/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
10/09/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/03/2024
Continuous trademark protection
Get notified about every new filing that threatens ZYPELZY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.